DK155003C - Analogifremgangsmaade til fremstilling af amidin-derivater eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af amidin-derivater eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK155003C
DK155003C DK410681A DK410681A DK155003C DK 155003 C DK155003 C DK 155003C DK 410681 A DK410681 A DK 410681A DK 410681 A DK410681 A DK 410681A DK 155003 C DK155003 C DK 155003C
Authority
DK
Denmark
Prior art keywords
addition salts
acid addition
acceptable acid
analogue
preparation
Prior art date
Application number
DK410681A
Other languages
Danish (da)
English (en)
Other versions
DK155003B (da
DK410681A (da
Inventor
Setsuro Fujii
Toshiyuki Okutome
Toyoo Nakayama
Takashi Yaegashi
Masateru Kurumi
Original Assignee
Torii & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12826980A external-priority patent/JPS5753454A/ja
Priority claimed from JP6494281A external-priority patent/JPS57179146A/ja
Application filed by Torii & Co Ltd filed Critical Torii & Co Ltd
Publication of DK410681A publication Critical patent/DK410681A/da
Publication of DK155003B publication Critical patent/DK155003B/da
Application granted granted Critical
Publication of DK155003C publication Critical patent/DK155003C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Power Steering Mechanism (AREA)
DK410681A 1980-09-16 1981-09-15 Analogifremgangsmaade til fremstilling af amidin-derivater eller farmaceutisk acceptable syreadditionssalte deraf DK155003C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP12826980A JPS5753454A (en) 1980-09-16 1980-09-16 Guanidinobenzoate and anticomplementary agent
JP12826980 1980-09-16
JP6494281A JPS57179146A (en) 1981-04-28 1981-04-28 Amidine compound
JP6494281 1981-04-28

Publications (3)

Publication Number Publication Date
DK410681A DK410681A (da) 1982-03-17
DK155003B DK155003B (da) 1989-01-23
DK155003C true DK155003C (da) 1989-05-29

Family

ID=26406084

Family Applications (1)

Application Number Title Priority Date Filing Date
DK410681A DK155003C (da) 1980-09-16 1981-09-15 Analogifremgangsmaade til fremstilling af amidin-derivater eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (17)

Country Link
US (2) US4454338A (cs)
EP (1) EP0048433B1 (cs)
KR (1) KR860000264B1 (cs)
AT (1) ATE20051T1 (cs)
AU (1) AU527371B2 (cs)
CA (1) CA1177488A (cs)
CS (1) CS228534B2 (cs)
DD (1) DD201779A5 (cs)
DE (1) DE3174717D1 (cs)
DK (1) DK155003C (cs)
ES (1) ES8206443A1 (cs)
FI (1) FI73975C (cs)
GB (1) GB2083818B (cs)
HU (1) HU185956B (cs)
NO (1) NO153568C (cs)
PH (1) PH18109A (cs)
SU (1) SU1176832A3 (cs)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine
FR2500825B1 (fr) * 1981-02-27 1985-08-23 Torii & Co Ltd Nouveau carboxylate de 4-amidino-phenyle substitue, son procede de preparation et agent anti-complement en comprenant
JPS57179147A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine derivative
JPS59139357A (ja) * 1983-01-28 1984-08-10 Torii Yakuhin Kk アミジン誘導体
US4818273A (en) * 1983-11-14 1989-04-04 The Dow Chemical Company Substituted 1,2,4-triazolo[1,5-a]pyrimidine-2-sulfonamides, compositions containing them, and their utility as herbicides
US4563527A (en) * 1984-07-19 1986-01-07 Torii & Co., Ltd. Amidine compounds
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
FR2568253B1 (fr) * 1984-07-26 1987-01-30 Torii Co Nouvelle amidine
GB2162171B (en) * 1984-07-26 1988-01-27 Torii & Co Ltd Amidine compounds
DE3427865A1 (de) * 1984-07-27 1986-02-06 Torii & Co., Tokio/Tokyo Amidinoverbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
US4709082A (en) * 1984-10-25 1987-11-24 Nissan Chemical Industries, Ltd. 2-phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof
AU584502B2 (en) * 1987-03-30 1989-05-25 Shosuke Okamoto Phenylalanine derivatives and proteinase inhibitor
US4990537A (en) * 1988-07-11 1991-02-05 Banyu Pharmaceutical Co., Ltd. Anti influenza agent
US5116985A (en) * 1989-12-28 1992-05-26 Snow Brand Milk Products Co., Ltd. Isoquinoline derivatives and salts thereof
ES2073502T3 (es) * 1989-12-28 1995-08-16 Snow Brand Milk Products Co Ltd Derivados de isoquinolina y sus sales como inhibidores de la proteasa.
US5238964A (en) * 1990-04-05 1993-08-24 Torii & Co., Ltd. Agent for treatment of cerebrovascular contraction
JPH078789B2 (ja) * 1990-04-05 1995-02-01 鳥居薬品株式会社 脳血管攣縮治療剤
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
EP0703216B1 (en) * 1994-09-20 1999-04-07 Ono Pharmaceutical Co., Ltd. Amidinophenol derivatives as protease inhibitors
DE69529770T2 (de) * 1994-12-02 2003-12-24 Yamanouchi Pharmaceutical Co., Ltd. Neues amidinonaphthylderivat oder dessen salz
CA2208032C (en) * 1995-01-05 2003-12-23 Torii Pharmaceutical Co., Ltd. Substituted amidinonaphthyl ester derivative
KR20000005312A (ko) 1996-04-10 2000-01-25 오노 야꾸힝 고교 가부시키가이샤 트립타아제 억제제 및 신규 구아니디노 유도체
AU7808198A (en) 1997-06-03 1998-12-21 Biocryst Pharmaceuticals, Inc. Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
AU1208999A (en) * 1997-11-10 1999-05-31 Array Biopharma, Inc. Compounds which inhibit tryptase activity
US6066673A (en) * 1998-03-12 2000-05-23 The Procter & Gamble Company Enzyme inhibitors
CA2320900C (en) 1998-03-19 2009-10-27 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
EP1066272A4 (en) * 1998-03-27 2002-03-13 Biocryst Pharm Inc NEW CONNECTIONS USEFUL IN THE COMPLEMENT, COAGULATE AND KALLIKREIN REACTION WAY AND METHOD FOR THEIR PRODUCTION
WO1999055661A1 (en) * 1998-04-24 1999-11-04 Proteus Molecular Design Limited Aminomethyl-benzoic ester derivatives as tryptase inhibitors
US6362216B1 (en) 1998-10-27 2002-03-26 Array Biopharma Inc. Compounds which inhibit tryptase activity
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および/または線溶系酵素阻害剤との組み合わせからなる医薬
BR0315942A (pt) * 2002-11-27 2005-10-04 Dmi Biosciences Inc Tratamento de doenças e condições mediadas pelo aumento de fosforilação
US20050192348A1 (en) * 2003-09-25 2005-09-01 David Bar-Or Methods and products which utilize N-acyl-L-aspartic acid
DE602006020434D1 (de) * 2005-05-17 2011-04-14 Santen Pharmaceutical Co Ltd Ein aminderivat als wirkstoff enthaltender angiogeneseinhibitor
US20090088472A1 (en) * 2005-05-17 2009-04-02 Kouji Oohashi Protective Agent for Neuronal Cell Comprising Amidino Derivative as Active Ingredient
GB2445920A (en) * 2007-01-25 2008-07-30 Mucokinetica Ltd Amidino compounds for treatment of respiratory disease
JPWO2010005087A1 (ja) * 2008-07-11 2012-01-05 味の素株式会社 アミジン誘導体
EP2349241B1 (en) 2008-10-17 2019-06-19 Signature Therapeutics, Inc. Pharmaceutical compositions with attenuated release of phenolic opioids
CA2773340C (en) 2009-09-08 2019-07-23 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
US20110262355A1 (en) 2010-04-21 2011-10-27 Jenkins Thomas E Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
US9238020B2 (en) 2010-04-21 2016-01-19 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
DK2560486T3 (en) 2010-04-21 2019-02-04 Signature Therapeutics Inc COMPOSITIONS COMPREHENSIVE ENZYM-TENDABLE AMPHETAMINE PRODRUGS AND ITS INHIBITORS
KR101942590B1 (ko) 2010-07-09 2019-01-25 비에이치브이 파르마, 인크. 레모글리플로진을 포함하는 짧은 반감기 약제용의 즉시/지연 조합 방출 전달 시스템
CN103384472B (zh) 2011-01-11 2016-01-20 特色疗法股份有限公司 包含酶可裂解的羟考酮药物前体的组合物
US8497237B2 (en) 2011-01-11 2013-07-30 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable oxycodone prodrug
WO2012122422A2 (en) 2011-03-09 2012-09-13 Signature Therapeutics, Inc. Active agent prodrugs with heterocyclic linkers
WO2012122420A2 (en) 2011-03-09 2012-09-13 Pharmacofore, Inc. Opioid prodrugs with heterocyclic linkers
PL2757093T3 (pl) 2011-09-15 2017-06-30 Astellas Pharma Inc. Związek, kwas guanidynobenzoesowy
CN103012214A (zh) * 2011-09-28 2013-04-03 南京长澳医药科技有限公司 一种萘莫司他盐酸盐及萘莫司他甲磺酸盐的制备方法
SI2975023T1 (sl) * 2013-03-13 2018-10-30 Takeda Pharmaceutical Company Limited Spojina ester gvanidinobenzojske kisline
CN103641749B (zh) * 2013-12-02 2016-02-10 山东永泰化工有限公司 一种甲磺酸萘莫司他的制备方法
US9346776B2 (en) 2014-02-13 2016-05-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
US9428470B2 (en) 2014-02-13 2016-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
CN110330447B (zh) * 2019-07-16 2022-04-15 北京赛升药业股份有限公司 一种甲磺酸萘莫司他中间体的制备方法及其应用
US20230210807A1 (en) * 2020-01-21 2023-07-06 Academy Of Military Medical Sciences Use of benzoate compound in treatment of sars-cov-2 infections
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN111574409A (zh) * 2020-05-14 2020-08-25 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) 一种甲磺酸萘莫司他的重结晶工艺方法
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.
CN113999145B (zh) * 2021-11-12 2023-02-03 开封明仁药业有限公司 一种甲磺酸萘莫司他的合成方法
AU2022422584A1 (en) 2021-12-23 2024-05-30 Subintro Limited Novel antiviral compositions comprising oleic acid
CN118439976A (zh) * 2024-04-25 2024-08-06 南京海纳医药科技股份有限公司 一种甲磺酸萘莫司他晶型及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD89611A (cs) *
DE1905813A1 (de) * 1968-07-04 1970-03-05 Akad Wissenschaften Ddr 3- oder 4-Guanidobenzoesaeurebenzyl- oder -phenylestern und deren Verwendung als Inhibitoren
GB1472700A (en) * 1974-11-01 1977-05-04 Ono Pharmaceutical Co Guanidinobehzoic acid derivatives and process for preparing the same
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine

Also Published As

Publication number Publication date
NO813138L (no) 1982-03-17
PH18109A (en) 1985-03-22
CA1177488A (en) 1984-11-06
FI73975B (fi) 1987-08-31
US4532255A (en) 1985-07-30
NO153568C (no) 1986-05-21
HU185956B (en) 1985-04-28
KR830007527A (ko) 1983-10-21
ES505460A0 (es) 1982-08-16
CS228534B2 (en) 1984-05-14
DK155003B (da) 1989-01-23
FI73975C (fi) 1987-12-10
NO153568B (no) 1986-01-06
EP0048433B1 (en) 1986-05-28
EP0048433A3 (en) 1982-07-21
DE3174717D1 (en) 1986-07-03
FI812876L (fi) 1982-03-17
AU527371B2 (en) 1983-03-03
ES8206443A1 (es) 1982-08-16
DD201779A5 (de) 1983-08-10
ATE20051T1 (de) 1986-06-15
US4454338A (en) 1984-06-12
GB2083818A (en) 1982-03-31
EP0048433A2 (en) 1982-03-31
SU1176832A3 (ru) 1985-08-30
KR860000264B1 (ko) 1986-03-22
DK410681A (da) 1982-03-17
GB2083818B (en) 1984-05-10
AU7506281A (en) 1982-03-25

Similar Documents

Publication Publication Date Title
DK155003C (da) Analogifremgangsmaade til fremstilling af amidin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DE2861729D1 (en) Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
DK151884C (da) Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK258078A (da) Fremgangsmaade til fremstilling af 7alfa-methoxy-7beta-(1,3-dithiethan-2-carboxamido) cephalosporansyre-derivater
DK151017C (da) Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK148596C (da) Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK148744C (da) Analogifremgangsmaade til fremstilling af den enkelte isomere eller en isomerblanding af spiro-(1,3-dioxolan-4,3') quinuclidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK149841C (da) Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK160498C (da) Analogifremgangsmaade til fremstilling af 3-methyl-flavon-8-carboxylsyreestere eller farmaceutisk acceptable syreadditionssalte deraf
DK144417C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive alfa-(3,4-dimethoxyphenethylaminomethyl)-2-alkoxybenzylalkoholer eller farmaceutisk anvendelige syreadditionssalte deraf
DK15282A (da) Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK152211C (da) Analogifremgangsmaade til fremstilling af n-phenyl-n-(4-piperidinyl)-amider eller farmaceutisk acceptable syreadditionssalte deraf.
DK148903C (da) Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK149750C (da) Analogifremgangsmaade til fremstilling af n-alkenylmoranolin-derivater eller farmaceutiske acceptable syreadditionssalte deraf
DK149889C (da) Analogifremgangsmaade til fremstilling af dibenzo(d,g)(1,3,6)dioxazocinderivater eller syreadditionssalte deraf
DK150481C (da) Analogifremgangsmaade til fremstilling af 3',4'-dihydro-spiro-(imidazolidin-4,1'-(2'h)-naphthalen)-5-on eller farmaceutisk acceptable syreadditionssalte deraf
BG34033A3 (en) A method of obtaining optically active, at a given time substituted 2- amino- 2- phenyl acetic acid
DK150158C (da) Analogifremgangsmaade til fremstilling af 4-phenylthieno-(2,3-c)piperidiner eller fysiologisk acceptable syreadditionssalte deraf
DK153025C (da) Analogifremgangsmaade til fremstilling af cysteinderivat eller farmaceutisk acceptable syreadditionssalte deraf
DK155942C (da) Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
GB1470747A (en) Pyridazine derivative
DK149588C (da) Analogifremgangsmaade til fremstilling af decahydroquinolinolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK159317C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazolin-(2)-derivater eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PUP Patent expired